Senseonics (NYSE:SENS) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS - Free Report) in a research note released on Friday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright reissued a "buy" rating and set a $2.00 price objective on shares of Senseonics in a report on Wednesday, August 14th.

Senseonics Stock Performance

Shares of Senseonics stock traded down $0.04 on Friday, hitting $0.31. The stock had a trading volume of 10,141,837 shares, compared to its average volume of 2,794,578. The stock has a market cap of $165.17 million, a price-to-earnings ratio of -2.37 and a beta of 0.79. The company has a current ratio of 3.11, a quick ratio of 2.89 and a debt-to-equity ratio of 59.17. Senseonics has a 52-week low of $0.30 and a 52-week high of $0.75. The company's 50 day moving average price is $0.35 and its 200 day moving average price is $0.40.

Senseonics (NYSE:SENS - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.03) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.03). The firm had revenue of $4.87 million for the quarter, compared to analyst estimates of $4.86 million. Senseonics had a negative return on equity of 299.69% and a negative net margin of 335.15%. On average, research analysts anticipate that Senseonics will post -0.13 EPS for the current year.

Hedge Funds Weigh In On Senseonics

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in shares of Senseonics by 0.7% in the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company's stock valued at $11,963,000 after buying an additional 155,715 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in Senseonics by 30.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company's stock worth $483,000 after acquiring an additional 211,128 shares during the period. Symmetry Partners LLC acquired a new position in Senseonics in the 3rd quarter valued at $164,000. Cubist Systematic Strategies LLC lifted its stake in shares of Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company's stock worth $166,000 after purchasing an additional 85,501 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of Senseonics by 16.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company's stock worth $196,000 after purchasing an additional 51,000 shares during the last quarter. Hedge funds and other institutional investors own 12.36% of the company's stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.